Pharmacological evaluation of physcion as a TRPV1 inhibitor with multimodal analgesic efficacy in experimental pain models
Hanbin Chen(Peking University), Jin‐Song Bian(Southern University of Science and Technology), Simon Ming‐Yuen Lee(Hong Kong Polytechnic University), Linhong Deng(Changzhou University), Shuli Li(University of Macau), Xiaowei Nie(Southern University of Science and Technology), Songqiang Huang(China Southern Power Grid (China)), G. Li(Southern University of Science and Technology)
Cited by 4
Related Papers
Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines
|Nature Communications|2020|613
Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response
|Proceedings of the National Academy of Sciences|2018|410
A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?
|Antioxidants and Redox Signaling|2018|405
Hydrogen sulfide attenuates lipopolysaccharide‐induced inflammation by inhibition of p38 mitogen‐activated protein kinase in microglia
|Journal of Neurochemistry|2006|307
Role of Hydrogen Sulfide in the Cardioprotection Caused by Ischemic Preconditioning in the Rat Heart and Cardiac Myocytes
|Journal of Pharmacology and Experimental Therapeutics|2006|264